BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  CSA Medical, Inc. Selected to Present at Mid-Atlantic Bio Conference

  October 29, 2010

   · 

  2 min read
• Business

  Mettler-Toledo to Host Third-Quarter 2010 Earnings Conference Call

  October 29, 2010

   · 

  1 min read
• Drug Development

  MAP Pharmaceuticals, Inc. to Present Data Showing Low Migraine Recurrence Rates With LEVADEX(TM) in FREEDOM-301 Trial

  October 29, 2010

   · 

  6 min read
• FDA

  FDA Nixes VIVUS, Inc.’s Qnexa; Asks For More Safety Data

  October 29, 2010

   · 

  6 min read
• Business

  Sanofi-Aventis (France): Resilient Sales and Business EPS(1) in Q3 2010

  October 29, 2010

   · 

  7 min read
• Deals

  Sanofi-Aventis (France) Will Pay $521 Million to Acquire BMP Sunstone

  October 29, 2010

   · 

  8 min read
• Business

  Covance Inc. and Sanofi-Aventis (France) Finalize Agreements for 10-year Strategic R&D Alliance

  October 29, 2010

   · 

  2 min read
• Business

  GlaxoSmithKline Licenses Amicus Therapeutics, Inc.’ Fabry Disease Drug For Upfront Payment of $30 Million and Eligible for Milestone Payments of $170 Million; Plus Glaxo Investing Another $31 Million for 20% Stake in Amicus

  October 29, 2010

   · 

  5 min read